ft 18 mar 93 technolog up down hypertens high blood pressur treatment work well scientist look beyond tradit cure write clive cookson seri drug discoveri drug bring high blood pressur one great success pharmaceut research past decad industri given doctor dozen new drug treat hypertens medic name condit sever differ mechan sale worth dollar 10bn pound 7bn year three time much total market cancer drug treatment hypertens good side effect minor say desmond julian medic director british heart foundat rang drug normal find one suit particular patient industrialis countri 15 20 per cent adult popul high blood pressur julian say patient mild moder hypertens put drug straightaway doctor urg make chang diet lifestyl 5 per cent peopl sever hypertens drug usual requir bring blood pressur safe level clinic trial shown greatest benefit hypertens treatment 40 per cent reduct risk suffer stroke caus ruptur blood vessel brain effect form cardiovascular diseas less clear cut inde still statist proof lower blood pressur cut risk fatal heart attack four main categori anti hypertens drug order increas novelti price diuret reduc volum blood increas flow urin bodi secondari effect open small arteri remov sodium diuret cheap patent drug beta blocker slow heart beat particularli exercis emot stress ici tenormin first blockbust anti hypertens recent lost patent protect calcium channel blocker relax blood vessel block flow calcium ion surround muscl patent also expir first group calcium blocker introduc mid 1970 bayer adalat ace inhibitor block angiotensin convert enzym ace prevent format angiotensin ii potent constrictor blood vessel pioneer ace inhibitor bristol myer squibb capoten launch 1981 recent overtaken merck vasotec world best sell heart drug face wide select drug doctor find best one patient accord julian major peopl matter trial error quit arbitrari drug start treatment hypertens vari consider countri countri cost consciou uk normal practic start patient cheap diuret beta blocker respons unsatisfactori move expens drug us doctor like prescrib calcium blocker ace inhibitor first line therapi attempt gather inform long term effect differ therapi two larg scale clinic comparison plan one europ organis peter sever st mari hospit london behalf british hypertens societi one us sponsor nation heart blood lung institut trial cost least pound 35m involv 30 000 peopl high blood pressur treat five year either diuret ace inhibitor calcium channel blocker result show ifth premium price charg new drug justifi superior perform lower blood pressur reduc death heart attack cardiovascular diseas trial may confound expect show diuret give mani benefit ace inhibitor calcium blocker way recent isi 3 mega comparison heart attack treatment undermin sale expens new clot buster tpa eminas show cheap old streptokinas effect compar clinic data becom avail sale compet hypertens drug depend market skill manufactur fierc competit differ class medicin also within class inde ace inhibitor sector best exampl today develop pharmaceut industri tom mckillop technic director zeneca pharmaceut soon spun ici say ace inhibitor unusu sector drug market strong competit sever patent product exert downward pressur price similar introduc gener patent drug matur sector ultim anti hypertens yet found say clae wilhelmsson research director astra sweden largest pharmaceut compani stop research tradit hypertens drug mani product market bring blood pressur safe effect compani tri produc new one say jurgen reden research director germani hoechst look drug someth reduc blood pressur exampl produc protect effect cardiac muscl avoid chronic cardiovascular diseas ace inhibitor show benefici side effect beyond control hypertens seem protect effect kidney function improv gener condit blood vessel compani cardiovascular research programm therefor explor way interven elsewher metabol pathway control blood pressur heart function renin angiotensin system kallikrein kinin system exampl jurgen drew research director switzerland roch say compani investig new class renin inhibitor would act begin process lead high blood pressur overal aim research accord reden round protect heart keep blood vessel wall clean good condit high blood pressur result interplay multipl genet environment factor research find great long term signific announc last octob academ team franc us head jean marc lalouel univers utah identifi first human gene link hypertens variat angiotensinogen gene found relat hypertens famili pari salt lake citi believ affect blood pressur control retent salt bodi scientist say least four gene perhap mani 20 like involv hypertens identifi possibl develop genet test identifi peopl risk perhap eventu think correct genet defect gene therapi howev sever point high blood pressur undoubtedli diseas western civilis although genet link extrem import interest find rememb environ live also control blood pressur say one live african desert ever suffer hypertens seri continu next month look treatment hay fever allergi top 10 high blood pressur drug 1991 brand compani categori sale dollar vasotec merck ace inhibitor 1 745 capoten bristol myer squibb ace inhibitor 1 580 tenormin ici zeneca beta blocker 1 180 cardizem marion merrel dow calcium channel blocker 912 procardia xl pfizer calcium channel blocker 896 adalat bayer calcium channel blocker 850 calan monsanto calcium channel blocker 508 trental hoechst vasodil 399 zestril ici zeneca ace inhibitor 395 lopresor ciba geigi beta blocker 345 sourc datamonitor